ISSN 2394-5125
 

Research Article 


CASE STUDY ON THE TREATMENT OF ALPRAZOLAM AND LOSARTAN SELF-HARMFUL INGESTION: A PUBLIC HOSPITAL ENCOUNTER

Khayati Moudgil, Keerthana Kumar, Balaji Shanmugavel, Sivasankaran Ponnusankar.

Abstract
Alprazolam belongs to the class of benzodiazepine and is a psychoactive short-acting drug that causes anxiolytic, hypnotic, and anticonvulsant influence. It is widely used in the diagnosis of insomnia, sleeplessness and psychotic disorders. Losartan is a blocker of angiotensin II (ARB) receptors that relaxes the blood vessels. This is used along with high blood pressure to reduce the risk of stroke, and is widely used to decrease high blood pressure. Here we record a case of the alleged ingestion by a 36-year-old male of two different tablets Alprazolam 1 mg in ten numbers and Losartan 50 mg fifteen tablets with self-harming intent. Patient was treated using normal detoxification and supportive care procedures.

Key words: Alprazolam, Losartan, Self-harming, Poisoning, Alleged consumption, Detoxification.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Khayati Moudgil
Articles by Keerthana Kumar
Articles by Balaji Shanmugavel
Articles by Sivasankaran Ponnusankar
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Khayati Moudgil, Keerthana Kumar, Balaji Shanmugavel, Sivasankaran Ponnusankar. CASE STUDY ON THE TREATMENT OF ALPRAZOLAM AND LOSARTAN SELF-HARMFUL INGESTION: A PUBLIC HOSPITAL ENCOUNTER. JCR. 2020; 7(9): 552-553. doi:10.31838/jcr.07.09.109


Web Style

Khayati Moudgil, Keerthana Kumar, Balaji Shanmugavel, Sivasankaran Ponnusankar. CASE STUDY ON THE TREATMENT OF ALPRAZOLAM AND LOSARTAN SELF-HARMFUL INGESTION: A PUBLIC HOSPITAL ENCOUNTER. http://www.jcreview.com/?mno=112213 [Access: May 30, 2021]. doi:10.31838/jcr.07.09.109


AMA (American Medical Association) Style

Khayati Moudgil, Keerthana Kumar, Balaji Shanmugavel, Sivasankaran Ponnusankar. CASE STUDY ON THE TREATMENT OF ALPRAZOLAM AND LOSARTAN SELF-HARMFUL INGESTION: A PUBLIC HOSPITAL ENCOUNTER. JCR. 2020; 7(9): 552-553. doi:10.31838/jcr.07.09.109



Vancouver/ICMJE Style

Khayati Moudgil, Keerthana Kumar, Balaji Shanmugavel, Sivasankaran Ponnusankar. CASE STUDY ON THE TREATMENT OF ALPRAZOLAM AND LOSARTAN SELF-HARMFUL INGESTION: A PUBLIC HOSPITAL ENCOUNTER. JCR. (2020), [cited May 30, 2021]; 7(9): 552-553. doi:10.31838/jcr.07.09.109



Harvard Style

Khayati Moudgil, Keerthana Kumar, Balaji Shanmugavel, Sivasankaran Ponnusankar (2020) CASE STUDY ON THE TREATMENT OF ALPRAZOLAM AND LOSARTAN SELF-HARMFUL INGESTION: A PUBLIC HOSPITAL ENCOUNTER. JCR, 7 (9), 552-553. doi:10.31838/jcr.07.09.109



Turabian Style

Khayati Moudgil, Keerthana Kumar, Balaji Shanmugavel, Sivasankaran Ponnusankar. 2020. CASE STUDY ON THE TREATMENT OF ALPRAZOLAM AND LOSARTAN SELF-HARMFUL INGESTION: A PUBLIC HOSPITAL ENCOUNTER. Journal of Critical Reviews, 7 (9), 552-553. doi:10.31838/jcr.07.09.109



Chicago Style

Khayati Moudgil, Keerthana Kumar, Balaji Shanmugavel, Sivasankaran Ponnusankar. "CASE STUDY ON THE TREATMENT OF ALPRAZOLAM AND LOSARTAN SELF-HARMFUL INGESTION: A PUBLIC HOSPITAL ENCOUNTER." Journal of Critical Reviews 7 (2020), 552-553. doi:10.31838/jcr.07.09.109



MLA (The Modern Language Association) Style

Khayati Moudgil, Keerthana Kumar, Balaji Shanmugavel, Sivasankaran Ponnusankar. "CASE STUDY ON THE TREATMENT OF ALPRAZOLAM AND LOSARTAN SELF-HARMFUL INGESTION: A PUBLIC HOSPITAL ENCOUNTER." Journal of Critical Reviews 7.9 (2020), 552-553. Print. doi:10.31838/jcr.07.09.109



APA (American Psychological Association) Style

Khayati Moudgil, Keerthana Kumar, Balaji Shanmugavel, Sivasankaran Ponnusankar (2020) CASE STUDY ON THE TREATMENT OF ALPRAZOLAM AND LOSARTAN SELF-HARMFUL INGESTION: A PUBLIC HOSPITAL ENCOUNTER. Journal of Critical Reviews, 7 (9), 552-553. doi:10.31838/jcr.07.09.109